TLDR Ethosomes can effectively deliver drugs deep into the skin, improving treatment for various skin conditions.
Ethosomes, innovative carriers capable of overcoming the skin barrier, showed potential for delivering drugs into deeper skin layers, enhancing dermal therapy. The document reviewed the efficiency of ethosomal delivery systems containing drugs like acyclovir, clindamycin, minoxidil, cannabidiol, and erythromycin in both ex vivo and in vivo studies. These systems aimed to improve treatments for bacterial and viral skin infections, rheumatoid arthritis, and pilosebaceous structure-related disorders, potentially increasing drug-treatment efficiency and patient convenience.
222 citations,
January 2003 in “Critical Reviews in Therapeutic Drug Carrier Systems” Ethosomes can safely and effectively deliver various drugs deep into the skin.
182 citations,
January 2000 in “Drug Development Research” Ethosomal carriers improve drug delivery through the skin better than traditional methods.
1 citations,
November 2022 in “Aaps Pharmscitech” 1 citations,
February 2024 in “Pharmaceutics” Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.
13 citations,
October 2012 in “InTech eBooks” Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.
7 citations,
October 2017 in “Artificial Cells Nanomedicine and Biotechnology” Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.
33 citations,
July 2021 in “Clinical, Cosmetic and Investigational Dermatology” Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.
